Several early-stage clinical trials indicate that implanting patients with the cells is safe. But whether they can alleviate neurological problems remains to be seen.

The move will allow the Belgium-headquartered biopharmaceutical giant to boost its work on treatments for rare diseases.

The widely expected move comes months after the companies scrapped trials of another Alzheimer’s drug.

A Chicago-based center that has long operated a clinical trial program for stem cell therapies, has stopped recruiting further patients as its chief, Richard Burt, leaves for a research sabbatical.

Antibiotics disrupt the immune response to the influenza vaccine in people who haven’t recently had exposure to the virus or immunization.

The patient’s vision has improved since the procedure, and her cornea remains clear.

Despite a solid understanding of the biological basis of fragile X syndrome, researchers have struggled to develop effective treatments.

REGN-EB3 and mAb114 reduced mortality in a clinical trial carried out during the ongoing outbreak in Democratic Republic of Congo.

Researchers aim to deploy the trial in neighboring Democratic Republic of Congo, which has been ravaged by Ebola for a year.